Structural and Functional Studies of S-(2-Carboxyethyl)-L-Cysteine and S-(2-Carboxyethyl)-l-Cysteine Sulfoxide.
Molecules
; 27(16)2022 Aug 20.
Article
em En
| MEDLINE
| ID: mdl-36014554
Insecticidal non-proteinogenic amino acid S-(2-carboxyethyl)-L-cysteine (ß-CEC) and its assumed metabolite, S-(2-carboxyethyl)-l-cysteine sulfoxide (ß-CECO), are present abundantly in a number of plants of the legume family. In humans, these amino acids may occur as a result of exposure to environmental acrylonitrile or acrylamide, and due to consumption of the legumes. The ß-CEC molecule is a homolog of S-carboxymethyl-l-cysteine (carbocisteine, CMC), a clinically employed antioxidant and mucolytic drug. We report here detailed structural data for ß-CEC and ß-CECO, as well as results of in vitro studies evaluating cytotoxicity and the protective potential of the amino acids in renal tubular epithelial cells (RTECs) equipped with reporters for activity of seven stress-responsive transcription factors. In RTECs, ß-CEC and the sulfoxide were not acutely cytotoxic, but activated the antioxidant Nrf2 pathway. ß-CEC, but not the sulfoxide, induced the amino acid stress signaling, which could be moderated by cysteine, methionine, histidine, and tryptophan. ß-CEC enhanced the cytotoxic effects of arsenic, cadmium, lead, and mercury, but inhibited the cytotoxic stress induced by cisplatin, oxaliplatin, and CuO nanoparticles and acted as an antioxidant in a copper-dependent oxidative DNA degradation assay. In these experiments, the structure and activities of ß-CEC closely resembled those of CMC. Our data suggest that ß-CEC may act as a mild activator of the cytoprotective pathways and as a protector from platinum drugs and environmental copper cytotoxicity.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Carbocisteína
/
Cisteína
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article